CA Stock MarketDetailed Quotes
RX Biosyent Inc
- 8.510
- -0.140-1.62%
15min DelayMarket Closed May 6 16:00 ET
98.76MMarket Cap16.03P/E (TTM)
8.620High8.510Low2.43KVolume8.600Open8.650Pre Close20.90KTurnover9.21152wk High0.03%Turnover Ratio11.61MShares6.92552wk Low0.531EPS TTM76.55MFloat Cap12.422Historical High16.03P/E (Static)9.00MShs Float0.010Historical Low0.531EPS LYR1.27%Amplitude0.16Dividend TTM2.84P/B1Lot Size1.88%Div YieldTTM
About Biosyent Inc Company
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.
Company Profile
SymbolRX
Company NameBiosyent Inc
Founded1947
MarketTSX
Fiscal Year Ends12-31
Address2476 Argentia Road Suite 402
CityMississauga
CountryCAN
Zip CodeL5N 6M1
Phone+1 905 206-0013
Websitehttp://www.biosyent.com
Company Executives
- Name
- Position
- Salary
- Rene C. Goehrum
- Chairman of the Board, President and Chief Executive Officer
- --
- Robert March
- Vice President, Finance and Chief Financial Officer
- --
- Kevin Wilson
- Vice President, Community Health Business
- --
- Joost van der Mark
- Vice President, Corporate Development
- --
- Dr. Navid Ashrafi, M.D.
- Director, Medical and Regulatory Affairs
- --
- Sara C. Elford
- Independent Director
- --
- Stephen Wilton
- Independent Director
- --
- Larry Andrews
- Independent Director
- --
- Joseph Arcuri
- Independent Director
- --
- Peter D. Lockhard
- Lead Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg